Home Healthcare Pharmaceuticals Asia Pacific Neurodegenerative Disease Market

Asia Pacific Neurodegenerative Disease Market Size, Share & Trends Analysis Report By Disease Indication (Multiple Sclerosis, Parkinson's Disease, Alzheimer's Disease, Others), By Drug Type (Immunomodulator, Vesicular Monoamine Transporter 2 (VMAT2), Others), By Routes of Administration (Oral, Intravenous (IV) delivery, Others) and By Country (China, Korea, Japan, India, Australia, Taiwan, South East Asia, Rest of Asia-Pacific) Forecasts, 2026-2034

Last Updated: July 09, 2026 | Author: Debashree B | Format: | Report Code: SR3065DR | Pages: 80
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Asia Pacific Neurodegenerative Disease Market, By Disease Indication 2022-2034 (USD MILLION/ Units)
    1. Multiple Sclerosis
    2. Parkinson's Disease
    3. Alzheimer's Disease
    4. Others
  2. Asia Pacific Neurodegenerative Disease Market, By Drug Type 2022-2034 (USD MILLION/ Units)
    1. Immunomodulator
    2. Vesicular Monoamine Transporter 2 (VMAT2)
    3. Others
  3. Asia Pacific Neurodegenerative Disease Market, By Routes of Administration 2022-2034 (USD MILLION/ Units)
    1. Oral
    2. Intravenous (IV) delivery
    3. Others
  4. Regional Asia Pacific Neurodegenerative Disease Market
    1. APAC
      1. APAC Asia Pacific Neurodegenerative Disease Market By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      2. APAC Asia Pacific Neurodegenerative Disease Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      3. APAC Asia Pacific Neurodegenerative Disease Market By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
      4. China Asia Pacific Neurodegenerative Disease Market
        1. China Asia Pacific Neurodegenerative Disease Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Multiple Sclerosis
          2. Parkinson's Disease
          3. Alzheimer's Disease
          4. Others
        2. China Asia Pacific Neurodegenerative Disease Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Immunomodulator
          2. Vesicular Monoamine Transporter 2 (VMAT2)
          3. Others
        3. China Asia Pacific Neurodegenerative Disease Market By Routes of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous (IV) delivery
          3. Others
      5. Korea Asia Pacific Neurodegenerative Disease Market
        1. Korea Asia Pacific Neurodegenerative Disease Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Multiple Sclerosis
          2. Parkinson's Disease
          3. Alzheimer's Disease
          4. Others
        2. Korea Asia Pacific Neurodegenerative Disease Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Immunomodulator
          2. Vesicular Monoamine Transporter 2 (VMAT2)
          3. Others
        3. Korea Asia Pacific Neurodegenerative Disease Market By Routes of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous (IV) delivery
          3. Others
      6. Japan Asia Pacific Neurodegenerative Disease Market
        1. Japan Asia Pacific Neurodegenerative Disease Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Multiple Sclerosis
          2. Parkinson's Disease
          3. Alzheimer's Disease
          4. Others
        2. Japan Asia Pacific Neurodegenerative Disease Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Immunomodulator
          2. Vesicular Monoamine Transporter 2 (VMAT2)
          3. Others
        3. Japan Asia Pacific Neurodegenerative Disease Market By Routes of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous (IV) delivery
          3. Others
      7. India Asia Pacific Neurodegenerative Disease Market
        1. India Asia Pacific Neurodegenerative Disease Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Multiple Sclerosis
          2. Parkinson's Disease
          3. Alzheimer's Disease
          4. Others
        2. India Asia Pacific Neurodegenerative Disease Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Immunomodulator
          2. Vesicular Monoamine Transporter 2 (VMAT2)
          3. Others
        3. India Asia Pacific Neurodegenerative Disease Market By Routes of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous (IV) delivery
          3. Others
      8. Australia Asia Pacific Neurodegenerative Disease Market
        1. Australia Asia Pacific Neurodegenerative Disease Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Multiple Sclerosis
          2. Parkinson's Disease
          3. Alzheimer's Disease
          4. Others
        2. Australia Asia Pacific Neurodegenerative Disease Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Immunomodulator
          2. Vesicular Monoamine Transporter 2 (VMAT2)
          3. Others
        3. Australia Asia Pacific Neurodegenerative Disease Market By Routes of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous (IV) delivery
          3. Others
      9. Taiwan Asia Pacific Neurodegenerative Disease Market
        1. Taiwan Asia Pacific Neurodegenerative Disease Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Multiple Sclerosis
          2. Parkinson's Disease
          3. Alzheimer's Disease
          4. Others
        2. Taiwan Asia Pacific Neurodegenerative Disease Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Immunomodulator
          2. Vesicular Monoamine Transporter 2 (VMAT2)
          3. Others
        3. Taiwan Asia Pacific Neurodegenerative Disease Market By Routes of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous (IV) delivery
          3. Others
      10. South East Asia Asia Pacific Neurodegenerative Disease Market
        1. South East Asia Asia Pacific Neurodegenerative Disease Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Multiple Sclerosis
          2. Parkinson's Disease
          3. Alzheimer's Disease
          4. Others
        2. South East Asia Asia Pacific Neurodegenerative Disease Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Immunomodulator
          2. Vesicular Monoamine Transporter 2 (VMAT2)
          3. Others
        3. South East Asia Asia Pacific Neurodegenerative Disease Market By Routes of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous (IV) delivery
          3. Others
      11. Rest of Asia-Pacific Asia Pacific Neurodegenerative Disease Market
        1. Rest of Asia-Pacific Asia Pacific Neurodegenerative Disease Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Multiple Sclerosis
          2. Parkinson's Disease
          3. Alzheimer's Disease
          4. Others
        2. Rest of Asia-Pacific Asia Pacific Neurodegenerative Disease Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Immunomodulator
          2. Vesicular Monoamine Transporter 2 (VMAT2)
          3. Others
        3. Rest of Asia-Pacific Asia Pacific Neurodegenerative Disease Market By Routes of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Intravenous (IV) delivery
          3. Others
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.